MTN-037 Study Product Considerations

Slides:



Advertisements
Similar presentations
DIAS 3&4 Investigational Medicinal Products (IMP)
Advertisements

Tips to a Successful Monitoring Visit
1 MTN-003 Study Specific Training Randomization Overview.
ASPIRE TRAINING RANDOMIZATION & INITIAL DISPENSING Cindy Jacobson, PharmD (MTN) Jen Berthiaume/Missy Cianciola (SCHARP)
Study Product Adherence Counseling At Follow-up Visits
TerraNova School Test Coordinators Training September 10, 2014 Roger Traynham Office of Achievement and Accountability.
1 MTN-003 Training Specimen Labeling and Preparation for Entry into LDMS.
Pass out Medication Policy/Training Manual and Quiz
School Name Here 2010 NECAP Science Test Administrator Workshop.
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
1 MTN 003 Data Management Considerations SSP Sections 14, 15 & 17.
ASPIRE TRAINING Study Product Considerations & Accountability for Non-Pharmacy Staff.
For Medication Certified Staff Members Only.   Governs how we give medications in a school setting  States that each parish will develop, follow and.
MTN-028 Study Product Considerations Cindy Jacobson Lindsay Kramzer Microbicide Trials Network.
ACRIN 6698 Diffusion-weighted MRI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: An I-SPY 2 Trial Substudy Presented by:
Research, Evaluation and Accountability Test Coordinator’s Training Series Preparing Your School’s FCAT Retake Documents For Return.
Florida Standards Assessments Paper-Based Materials SCHOOL COORDINATOR RETURN INSTUCTIONS.
Procurement Card Presented By: Denise Matias, CAH February 1, 2012.
MTN-027 Study Product Considerations Cindy Jacobson Microbicide Trials Network Pittsburgh, PA USA.
Medications Training. The following presentation is designed to walk you through the process of administering medications to students. Please refer to.
GRITS Manage Orders Training Overview: Inventory and Manage Orders Functions 05/08/2014.
1 January 17, 2008 Test Article Accountability. 2 January 17, 2008 Investigator Responsibilities 21 CFR  Maintain control of drug under investigation.
Informed Consent Process: Key Considerations. Introduction  Informed consent is a requirement of ethical clinical research  Section 4.8 of the International.
Study Product Return Re-Supply and Re-Issue MTN-003 Study-Specific Training.
**INSERT YOUR TITLE HERE**
IP Accountability in Outpatient Clinical Trials
Pharmacist Training Revised September 2010
MTN-025/HOPE Decliner Population Procedures. Who are the Decliner Population? Former ASPIRE participants who decline or express no interest in joining.
IP Accountability in Outpatient Clinical Trials Jessica Rinaldi, CCRP Farber Institute for Neurosciences.
Vaccination POD Just-in-Time Training. A list of Vaccinators and Vaccinator Assistants at each station will be maintained by the Administrative Representative.
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
COMMUNITY PHARMACY WORKBOOK PUBLIC HEALTH DORSET
Medication POD Just-in-Time Training
Inventory Management Chapter 13.
Heath Reimbursement Account (HRA)
Planning for HOPE PUEVs and Study Exit Visits
Presbyterian College School of Pharmacy
Training Documentation – Replacing GSPR with RFQ 2.0
Protocol Deviations.
Prescribing, preparation and administration of the IMP including maintaining blinding V6.0 17/01/17.
MAINTAINING THE INVESTIGATOR’S SITE FILE
Off-Site Visit Procedures and Documentation Considerations
Field Inventory Services-Sanofi Inventory and Audit Training
MTN-025 Data Communiqué #1 CRF Updates.
Protocol References Section Title 6.2 Entry Visit 5.1
HOPE STUDY PRODUCT TRAINING PHASE 2
Protocol References Section Title 6.2 Entry Visit 5.1
Presented By: Denise Matias, CAH February 1, 2012
MTN-037 Training Julie Ngo SCHARP April 12, 2018.
MTN-026 Study Product Considerations
MTN-033 An Open Label Randomized Phase 1 Pharmacokinetic Study of Dapivirine Gel Administered Rectally to Seronegative Adults Protocol Overview.
Medication Education Module 6
Medication Education Module 5
Medication Education Module 5
Document Custodian of the Drop Safe Log
Fantastic Graphics Inc. 2017
Business Office Manager Training The ACH Process in 7 Steps
Protocol Requirements for Product Holds/ Discontinuations
Controlled Substances
Participant Retention
Audit Pharmacy Review Rosalyn D. Williams
THE TRIAL DATABASE AND ONLINE DATA QUERIES
Controlled Substances
Guide to completing ANDA-AQCA 2017
HOPE STUDY PRODUCT TRAINING
Medication Training Module IV Kenton County Schools
COMMUNITY PHARMACY WORKBOOK 2019 PUBLIC HEALTH DORSET
Good clinical practice
Nash-Rocky Mount Schools June 2019
Presentation transcript:

MTN-037 Study Product Considerations Cindy Jacobson/Lindsay Kramzer Microbicide Trials Network Pittsburgh, PA USA

Presentation Overview Study Gel Prescription Completion Study Gel Supply and Labeling Chain of Custody, Accountability, Unused Gel Returns Study Gel Request Slip Completion Study Gel Complaints

Reference Materials MTN-037 Protocol, Version 1.0 MTN-037 SSP Manual Section 6 MTN-037 SSP Manual

MTN-037 Study Product - Gel PC-1005 - Fixed dose combo 4 mL of gel contains 73.6 µg MIV-150 & 3.58 mg Zinc with Carrageenan as the gel vehicle PC-1005 should be stored at room temperature (77°F) Excursions are permitted (59-86°F)

Study Product Regimen & Visit Schedule

Visit 2/Day 0: Enrollment Visit Eligibility Criteria CRF must be completed by clinic staff for a participant to be enrolled into the study. A participant is considered officially enrolled after the completion of the Randomization CRF, as evidenced by the appearance of a date and time on this CRF. Site pharmacy staff will receive an email notification from the Medidata system when a participant is enrolled by site clinic staff.

Dosing Visits – Visits 3, 5, & 7 Completion of Prescription by clinic staff/authorized prescriber will occur at Visit 3, Visit 5, and Visit 7 Prescription is a 2 part no carbon required (NCR) paper document. The top white is the original (pharmacy) and the bottom is yellow (clinic) Prescriptions are provided by the MTN LOC Pharmacy to the site pharmacy staff who, in turn, provides this document supply to site clinic staff

MTN-037 Prescription When completing the prescription, place the cardboard flap under the copy (clinic prescription) Double check the accuracy of all entries Errors may be corrected in blue or black ink by putting a line through and initialing Retain the yellow copy for the participant study notebook in the clinic Deliver white copy to pharmacy

MTN-037 Prescription The pharmacist will review the prescription. If an error is noted, the white and yellow copies must be individually corrected by an authorized prescriber with identical information on both copies (correction, initials, date). The pharmacist will also let you know if he/she finds a discrepancy between information on the prescription and Pharmacy Dispensation CRF. If no problems are noted, the pharmacist will dispense the PC-1005 applicator and rectal tip.

MTN-037 PC-1005 Applicator

Tip For Rectal Administration

Chain Of Custody The study product must be tracked with documentation, from the pharmacy to the participant, all steps in between and the return documented in the clinic. Study product may be prepared by the pharmacist based on either original documents or faxed copies, but will not be released to the clinic staff until the original prescription is received. Upon receipt of a completed and signed prescription, the PoR will dispense study gel per the Study Visit Schedule.

Chain Of Custody Pharmacy site-specific Chain of Custody SOP Chain of Custody from pharmacy staff to clinic staff is documented on the Record of Receipt of Site-Specific PC-1005 This record is stored in the pharmacy

Record of Receipt of Site-Specific PC-1005

Chain of Custody Clinic Staff Responsibilities Control access to the study product in their custody. Clinic staff must document delivery of the study product to designated participants in the participants’ study charts (chart notes, visit checklists, or on other source documents designated for this purpose by clinic staff).

Chain of Custody Clinic Staff Responsibilities If study product dispensed for a participant is not provided to the participant, clinic staff must document this in the participant's study chart and return remaining product (unused) to the pharmacy.

PC-1005 Dosing What is documented on the Dose Administration CRF? Visit Number Dropdown List Visit 3 Visit 5 Visit 7 Date gel application administered Date NA Time gel application administered Time Dosage Administered 4 16 32

MTN-037 Study Gel Request Slip Study Gel Request Slip is a 2 part no carbon required (NCR) paper document. The top white is the original (pharmacy) and the bottom is yellow (clinic). Request Slips are provided by the MTN LOC Pharmacy to the site pharmacy staff who, in turn, provides this document supply to site clinic staff Clinic staff will complete a request slip, if: Additional product is needed/resupply (one or more of the applicators is unusable) Temporary product hold Product resume after temp hold Permanent product discontinuation Participant decline of product use Product use period completed (expected use of slip at Visit 8)

Study Gel Request Slip Completion This slip can be completed by any authorized clinic staff except in the case of indicating “RESUME” Only authorized prescribers can indicate “RESUME” Insert cardboard flap behind the clinic copy Double check the accuracy of all entries Errors may be corrected in blue or black ink by putting a line through and initialing Retain the yellow copy for the participant study notebook in the clinic Deliver white copy to pharmacy Once the white and yellow copies are separated errors must be corrected on each sheet separately

Unused PC-1005 Returns ONLY unused study gel should be returned to the pharmacy NO USED GEL APPLICATORS should be returned to the pharmacy Unused gel is returned to the pharmacy by: Clinic staff member or runner Depends on pharmacy site-specific Chain of Custody SOP Documented on Record of Return of Site-Specific PC-1005 This record is stored in the pharmacy

Chain Of Custody If returning unused gel because damaged or contaminated, record the details on the record The pharmacy will quarantine and document any returned unused gel

Record of Return of Site-Specific PC-1005

PC-1005 Complaints Study product problem may be noted by pharmacy, clinic, and/or participant. May concern dosage form (gel), packaging (vial, syringe, cap, or rectal tip), or other aspect. Clinic staff will make thorough record of clinic staff or participant complaint. Clinic staff member will email complaint to pharmacy PTID, Date of observed issue, date issue was reported, date gel was dispensed, did adverse event occur, nature of issue, picture (if possible and applicable), any other necessary details

PC-1005 Complaints Pharmacy staff will email all study product complaints to MTN LOC Pharmacy. If the complaint is concerning an unused PC-1005, then the unused gel should be held in quarantine in the pharmacy If the complaint is concerning a used gel applicator, then the clinic staff should process the used study product per standard operating procedures for used study products (if applicable)

Other Items Supplied to Clinic 50 male condoms 24 – 4mL sachets of lubricant for applicator insertion 3 – 4oz tubes of lubricant for procedures An order does not need to be submitted for these items

Contact Information If you have any questions, please do not hesitate to contact us: Cindy Jacobson (412) 641-8913 cjacobson@upmc.edu Lindsay Kramzer (412) 641-3865 fergusonlm@upmc.edu Questions? Thank you!